FDA Approves Botox Rival From Ipsen SA

Boston (HealthKnowItAll) - The Food and Drug Administration (FDA) have approved a new drug made by Ipsen SA and Medicis Pharmaceutical Corp to treat wrinkles in skin.

The drug is called Dysport, and will begin to rival botox, the current leading wrinkle remover on the market.

Botox is one of the most popular drugs on the market, as it can peal years off of a person’s appearance.

Botox was approved for medical use back in 1991, and then again in 2002 as a wrinkle remover.

According to the American Society for Aesthetic Plastic Surgery, last year more than 2.5 million people received botox injections in order to look younger.

Dysport works by producing a type of botulinum toxin in the skin that in turn, reduces the ability of facial muscles to begin the formation of wrinkles.

“We are excited to be entering the market for the most popular nonsurgical aesthetic procedure in the U.S., and anticipate being highly competitive,” said Jonah Shacknai, chief executive officer of Medicis, in a statement.